Article Details
Retrieved on: 2024-08-13 17:52:30
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article details Abeona Therapeutics' progress in developing pz-cel, a gene therapy for RDEB, emphasizing its regenerative medicine potential. The tags reflect this scope, including FDA designations, pharmaceuticals policy, and related biotechnological advancements impacting gene therapy for skin disorders.
Article found on: www.investing.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here